Key Financial Data Of Reporting Company

Fuso Pharmaceutical Industries,Ltd. - Filing #7732502

Concept As at
2017-09-30
2017-07-01 to
2017-09-30
2017-04-01 to
2017-09-30
2016-04-01 to
2017-03-31
As at
2017-03-31
2016-07-01 to
2016-09-30
As at
2016-09-30
2016-04-01 to
2016-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
23,066,000,000 JPY
46,782,000,000 JPY
23,718,000,000 JPY
Ordinary profit (loss)
403,000,000 JPY
642,000,000 JPY
514,000,000 JPY
Profit (loss)
265,000,000 JPY
861,000,000 JPY
406,000,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
10,758,000,000 JPY
10,758,000,000 JPY
10,758,000,000 JPY
Total number of issued shares
9,451,169 xbrli:shares
9,451,169 xbrli:shares
94,511,690 xbrli:shares
Net assets
32,062,000,000 JPY
32,545,000,000 JPY
32,197,000,000 JPY
Total assets
70,937,000,000 JPY
68,788,000,000 JPY
69,955,000,000 JPY
Dividend paid per share
40.00
44.00
4.00
Basic earnings (loss) per share
8.28
29.81
95.86
13.27
45.08
Diluted earnings per share
Equity-to-asset ratio
0.452 xbrli:pure
0.473 xbrli:pure
0.460 xbrli:pure
Net cash provided by (used in) operating activities
815,000,000 JPY
1,876,000,000 JPY
1,683,000,000 JPY
Net cash provided by (used in) investing activities
-1,160,000,000 JPY
-786,000,000 JPY
-733,000,000 JPY
Net cash provided by (used in) financing activities
1,973,000,000 JPY
-1,145,000,000 JPY
394,000,000 JPY
Cash and cash equivalents
6,579,000,000 JPY
4,951,000,000 JPY
6,349,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.